FUNDAMENTALS
EdgeFII/DII
MOLBIOMolbio Diagnostics Ltd
₹1,495.50-2.02%
Terminal
  • Overview
  • Price
  • Ratios
  • About
  • P&L
  • Balance
  • Cash flow
  • Holders
  • Actions
  • Peers
  • News
MOLBIONSE · EquityHealthcare

Molbio Diagnostics Ltd

ISIN
INE869T01028
Instrument key
NSE_EQ|INE869T01028
Open in terminal Fundamentals cached for 6 hours
Last traded price
₹1,495.50-30.90 · -2.02%
Day rangecircuit ₹1,196.40 – ₹1,794.60
1,483.10
1,580.00

as of 21/11/2026, 12:12:41 pm

Open
₹1,549.80
Day high
₹1,580.00
Day low
₹1,483.10
Prev. close
₹1,526.40
Volume
7.01 L
VWAP
₹1,530.99

On this page

Company

  • Overview
  • Price chart
  • Key ratios
  • About

Statements

  • Profit & loss
  • Balance sheet
  • Cash flow

Ownership

  • Shareholding
  • Corporate actions
  • Peers

Market

  • News

02/Price history

Price chart

1 year · daily candles. Hover the chart for the OHLC of any candle; the table below holds the same data row by row.

1D1W1M
6M
1Y
5Y
MAX
Change · 1Y
+43.56%
1,041.70 → 1,495.50
Period high
₹1,686.80
11/9/2026
Period low
₹926.35
17/8/2026
From high
-11.34%
+61.44% from low
Avg volume
25.86 L
17.33 Cr total
Volatility · ann.
83.1%
67 candles · 28 up / 39 down
20 Nov 2026O 1,549.80H 1,580.00L 1,483.10C 1,495.50Vol 7.01 L
SMA 20SMA 50Averages need 50 candles before they begin
Candle data67 rows of open, high, low, close and volumeShowHide
20 Nov 20261,549.801,580.001,483.101,495.50-3.50%96.907.01 L
19 Nov 20261,505.001,540.201,477.001,526.40+1.42%63.204.63 L
18 Nov 20261,499.001,517.301,458.001,497.60-0.09%59.303.57 L
17 Nov 20261,488.001,541.301,473.201,484.10-0.26%68.104.88 L
16 Nov 20261,510.001,529.901,475.101,486.40-1.56%54.805.67 L
13 Nov 20261,412.601,545.001,394.101,493.20+5.71%150.9023.04 L
12 Nov 20261,323.001,482.001,323.001,394.10+5.37%159.0022.77 L
11 Nov 20261,336.001,360.001,307.001,318.60-1.30%53.004.25 L
9 Nov 20261,357.301,370.601,322.201,336.00-1.57%48.401.54 L
8 Nov 20261,350.601,406.001,342.201,360.20+0.71%63.801.15 L

Historical price and volume data · Showing 1–10 of 67

1 / 7

03/Valuation & returns

Key ratios vs sector

Company value benchmarked against the sector median. The ratio set is sector specific — banks report NIM, CASA and Net NPA instead of EV/EBITDA.

P/E

Price ÷ earnings per share

121.64
Company
121.64
Sector
39.99

Worse than sector by 204%

P/B

Price ÷ book value per share

11.96
Company
11.96
Sector
4.0

Worse than sector by 199%

ROA

Net income ÷ total assets

6.08%
Company
6.08%
Sector
10.51%

Worse than sector by 42%

ROE

Net income ÷ shareholders' equity

10.72%
Company
10.72%
Sector
17.51%

Worse than sector by 39%

ROCE

EBIT ÷ capital employed

13.62%
Company
13.62%
Sector
18.73%

Worse than sector by 27%

Quick Ratio

Liquid assets ÷ current liabilities

1.68
Company
1.68
Sector
2.72

Worse than sector by 38%

EV/EBITDA

Enterprise value ÷ EBITDA

53.01
Company
53.01
Sector
14.77

Worse than sector by 259%

04/Business

About the company

Sector: Healthcare

Sector market cap (INR)
₹17,228 Cr

reported in crore

Sector market cap (USD)
$1.91B

reported in billion

Market capitalisation is reported at the sector-constituent level, not the standalone company level.

05/Profit & loss

Standalone income statement

Annual figures in ₹ crore. Growth marked reported is provided; margins are derived.

YearlyQuarterly
ConsolidatedStandalone
Revenue · Mar 2026
₹1,321 Cr
+35.14% vs Mar 2025
Net profit · Mar 2026
₹145 Cr
+3.93% vs Mar 2025
Operating margin
15.2%
was 19.2%
Revenue CAGR · 3p
31.6%
profit 14.4% · op 14.9%
Filed order
Revenue1,321978763
Revenue growthreported35.1%28.1%—
Operating profit201188152
Operating profit growthreported6.7%23.8%—
Operating marginderived15.2%19.2%19.9%
Net profit145140111
Net profit growthreported3.9%25.8%—
Net marginderived11.0%14.3%14.6%
EPS — basic₹/share, annual12.8312.409.86

Figures in ₹ crore. Margin rows are computed from the reported values.

06/Balance sheet

Standalone balance sheet

Only annual balance sheets are available — the quarterly filter does not apply here. Figures in ₹ crore; net worth is assets minus liabilities.

ConsolidatedStandalone
Total assets · Mar 2026
₹1,741 Cr
+33.13% YoY
Total liabilities
₹606 Cr
Net worth
₹1,135 Cr
Liabilities ÷ assets
34.8%
lower means a lighter balance sheet
Filed order
Total assets1,7411,3071,077920
Total liabilities606317227181
Net worthderived1,135990850739
Liabilities ÷ assetsderived34.8%24.3%21.1%19.6%
Asset growthderived33.1%21.4%17.1%—

Figures in ₹ crore. Stacked chart height equals total assets.

Full annual line itemsNon-current & current assets, liabilities, equity capitalShowHide
Filed order
Non-Current Assets737481354309
Current Assets1,004827724611
Total Assets1,7411,3071,077920
Current Liabilities382304210178
Net Current Asset622523514433
Non-Current Liabilities22413173
Equity Capital1,135990850739
Total Equity & Liabilities1,7411,3071,077920

Figures in ₹ crore unless the line item is per-share.

07/Cash flow

Standalone cash flow

Annual only, in ₹ crore. Negative values are outflows, so healthy companies usually show positive operating and negative investing cash flow.

ConsolidatedStandalone
Operating · Mar 2026
-₹38 Cr
-115.28% YoY
Investing
-₹256 Cr
Financing
₹292 Cr
Free cash flow
-₹294 Cr
operating + investing
Filed order
Operating activities-382493868
Operating changereported-115.3%558.7%-44.4%—
Investing activities-256-98-31-51
Investing changereported-161.8%-211.4%38.4%—
Financing activities292-17-2431
Financing changereported1785.2%28.3%-178.2%—
Net cash flowderived-2133-1848
Free cash flowoperating + investing-294151617

Figures in ₹ crore.

Full annual line itemsProfit before tax through closing cash balanceShowHide
Filed order
Profit before tax19818815223
Income before WC changes27624723842
Change in Assets-227-65-19158
Change in Liabilities-34131340
Change in WC-26166-15758
Cash flow from Operations-382493868
Cash flow from Investing-256-98-31-51
Cash flow from Financing292-17-2431
Total Cash Flow-2133-1848
Cash (Start of the year)111-23-5-52
Cash (End of the year)109111-23-5

Figures in ₹ crore unless the line item is per-share.

08/Ownership

Shareholding pattern

Percentage of total shares by holder category across the last 3 reported quarters. Sort any quarter column to rank holders by size.

Promoters
41.29%
0.00 pts QoQ
FII
1.59%
+0.08 pts QoQ
DII (other)
11.06%
-3.06 pts QoQ
Mutual funds
8.03%
+5.78 pts QoQ
Retail & others
38.03%
-2.79 pts QoQ
Filed order
Promoters41.3%41.3%46.6%
FII1.6%1.5%0.0%
DII (other)11.1%14.1%0.0%
Mutual funds8.0%2.3%0.0%
Retail & others38.0%40.8%53.4%
Promoters — QoQ changepts, derived0.0%-5.4%—
FII — QoQ changepts, derived0.1%1.5%—
DII (other) — QoQ changepts, derived-3.1%14.1%—
Mutual funds — QoQ changepts, derived5.8%2.3%—
Retail & others — QoQ changepts, derived-2.8%-12.5%—
Totalderived100.0%100.0%100.0%

Values are percentages of total outstanding shares; QoQ rows are percentage-point moves.

09/Events

Corporate actions

Dividends, bonuses, splits and rights issues. Filter by type, sort by any date, and expand a row for the full event detail.

No corporate actions on record

10/Comparison

Peers & competitors

Competitor set priced live. Filter by sector, sort any column, and expand a peer for its business description.

Sector
APOLLOHOSPApollo Hospitals Enter. LHealthcare Services₹9,200.00+5.29%14.13 L₹1,32,139 Cr$14.68B
MAXHEALTHMAX Healthcare INS LtdHealthcare Services₹1,081.00+3.88%95.32 L₹1,05,080 Cr$11.68B
MANIPALHOSManipal Health Enterpri LHealthcare₹702.20+0.83%11.62 L₹92,366 Cr$10.26B
ASTERDMAster DM Quality Care LtdHealthcare Services₹779.30+5.41%26.66 L₹67,960 Cr$7.55B
FORTISFortis Healthcare LtdHealthcare Services₹825.00+1.87%22.88 L₹62,284 Cr$6.92B
MEDANTAGlobal Health LimitedHealthcare Services₹1,480.20+0.13%2.65 L₹39,829 Cr$4.43B
NHNarayana Hrudayalaya Ltd.Healthcare Services₹1,945.00+3.84%7.85 L₹39,757 Cr$4.42B
LALPATHLABDR. LAL Path Labs Ltd.Healthcare Services₹1,989.00+1.31%2.65 L₹33,680 Cr$3.74B
KIMSKrishna Inst Of MED SCI LHealthcare Services₹795.60+3.62%10.44 L₹33,483 Cr$3.72B
SYNGENESyngene International LtdDiversified₹451.70+3.28%25.58 L₹18,240 Cr$2.03B

Market cap is the sector-constituent figure reported per peer · Showing 1–10 of 10

1 / 1

11/Coverage

Company news

Articles published in the last seven days, paginated by the provider.

No news in the last seven days

Company news is available for a rolling one-week window.

Full annual line itemsRevenue, other income, expenses, tax, EPS
ShowHide
Filed order
Revenue1,313971756327
Other Income8678
Total Revenue1,321978763335
Total Expenses1,120781584312
Profit Before Tax19818815223
Tax5348417
Profit After Tax14514011116
EPS - Basic12.8312.409.866.91
EPS - Diluted12.8312.409.856.90

This breakdown is available annually, even when the summary above is quarterly. EPS rows are per share.